Redsense Medical AB Total Liabilities
Redsense Medical AB total liabilities. Based on the latest financial reports, Redsense Medical AB (REDS) has total liabilities worth Skr3.89 Million SEK (≈ $418.95K USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Redsense Medical AB asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Redsense Medical AB (2020–2024)
Total liabilities of Redsense Medical AB from 2020 to 2024. This chart illustrates how Redsense Medical AB's total liabilities have evolved over time, based on quarterly financial data.
Redsense Medical AB Competitors by Total Liabilities
The table below lists competitors of Redsense Medical AB ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
ChoA Pharmaceutical Co.Ltd
KQ:034940
|
Korea | ₩41.51 Billion |
|
Shanghai Taihe Water Environmental Technology Development Co Ltd
SHG:605081
|
China | CN¥424.21 Million |
|
SINTX Technologies Inc
NASDAQ:SINT
|
USA | $7.30 Million |
|
Max Resource Corp
V:MAX
|
Canada | CA$2.13 Million |
|
RED LIGHT HOLLAND CORP.
F:4YX
|
Germany | €3.82 Million |
|
Pollen Street PLC
LSE:POLN
|
UK | GBX228.92 Million |
|
Equinox Resources Ltd
AU:EQN
|
Australia | AU$161.37K |
|
BAWAT WATER TECHNOLOGIES
F:M5W
|
Germany | €28.66 Million |
Liability Composition Analysis (2020–2024)
This chart breaks down Redsense Medical AB's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see REDS asset base.
Liquidity & Leverage Metrics
Redsense Medical AB Total Liabilities Ratios Explained
Redsense Medical AB total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 6.45 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.11 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.10 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Redsense Medical AB's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Redsense Medical AB (2020–2024)
The table below shows the annual total liabilities of Redsense Medical AB from 2020 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | Skr2.21 Million ≈ $238.05K |
-35.13% |
| 2023-12-31 | Skr3.41 Million ≈ $366.97K |
-4.80% |
| 2022-12-31 | Skr3.58 Million ≈ $385.48K |
-37.78% |
| 2021-12-31 | Skr5.76 Million ≈ $619.55K |
+4.58% |
| 2020-12-31 | Skr5.51 Million ≈ $592.43K |
-- |
About Redsense Medical AB
Redsense Medical AB (publ) develops a monitoring system to detect sign of a blood leak using patented fiber optic technology primarily in Europe, Canada, and the United States. The company offers Redsense System, a product that is used for monitoring and alarming in the case of blood leakage during hemodialysis treatment; and Redsense venous sensor patch, a noninvasive patch that consists of an o… Read more